SCHEMBL3693409

SCHEMBL3693409

N#CC(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA6 P23280 1/20 0.52
CA9 Q16790 1/20 0.52
AKR1C3 P42330 1/20 0.50
KMO O15229 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
UNG P13051 1/20 0.47
DAO P14920 1/20 0.46
TSHR P16473 1/20 0.46
NAPRT Q6XQN6 1/20 0.46
FOLH1 Q04609 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29661090 1.00 CA12 (0.52) CA12CA1CA2CA6CA9
SCHEMBL10933256 0.91 ATM (0.46) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL1557619 0.84 CA12 (0.68) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL20235879 0.84 CA12 (0.68) CA12CA1CA2CA6CA9
SCHEMBL24031434 0.82 TTR (0.44) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL15573241 0.82 CA12 (0.65) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL15571211 0.82 CA12 (0.65) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL15571519 0.82 CA12 (0.65) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL15572370 0.82 CA12 (0.65) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL147366 0.82 CA12 (0.71) CA12CA1CA2CA6CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035761-A1 High-throughput rna structure analysis UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE 2010-02-11 US claimed
WO-2007145940-A2 HIGH-THROUGHPUT RNA STRUCTURE ANALYSIS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2007-12-21 WO claimed
US-20240254107-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2024-08-01 US disclosed
CN-118119608-A RNA targeting ligands, compositions thereof, and methods of making and using the same 北卡罗来纳查佩尔山大学 2024-05-31 CN disclosed
EP-4337653-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME The University of North Carolina at Chapel Hill (US) 2024-03-20 EP disclosed
WO-2022256382-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2022-12-08 WO disclosed
US-20220289688-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2022-09-15 US disclosed
CN-114901654-A RNA-targeting ligands, compositions thereof, and methods of making and using the same 北卡罗来纳查佩尔山大学 2022-08-12 CN disclosed
EP-4010332-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME The University of North Carolina at Chapel Hill (US) 2022-06-15 EP disclosed
WO-2021026245-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2021-02-11 WO disclosed
US-8318424-B2 High-throughput RNA structure analysis THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-11-27 US disclosed
US-20100035761-A1 High-throughput rna structure analysis UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE 2010-02-11 US disclosed
WO-2007145940-A2 HIGH-THROUGHPUT RNA STRUCTURE ANALYSIS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2007-12-21 WO disclosed
WO-2007145940-A2 HIGH-THROUGHPUT RNA STRUCTURE ANALYSIS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289688-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME TARBP1, RNGTT, NSUN3 CA12 4457/4885CA1 4798/4885CA2 4786/4885
US-20100035761-A1 High-throughput rna structure analysis NSUN2, RNGTT, FBL CA12 4123/4885CA1 4053/4885CA2 4655/4885
US-20240254107-A1 RNA-TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME TARBP1, RNGTT, NSUN3 CA12 4457/4885CA1 4798/4885CA2 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.